Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Gliosarcoma 13Glioblastoma 12Sarcoma 3Astrocytoma 3Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Fibrosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Kidney Neoplasms 1Hemangiopericytoma, Malignant 1Glioma, Subependymal 1Glioma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Dermatofibrosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3aldesleukin 2Yoga 2Temozolomide 2Surveys and Questionnaires 2Paclitaxel 2Imatinib Mesylate 2Gadolinium DTPA 2Donepezil 2Carmustine 2Bortezomib 2vatalanib 1temsirolimus 1sargramostim 1olaparib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1entinostat 1carboxyamido-triazole 1Vorinostat 1Verteporfin 1Thalidomide 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Radiotherapy, Conformal × Sarcoma × Clear all
NCT01119599 2015-09-29

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
22 enrolled
CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroma, Acoustic, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡